SS
PTCT icon

SBI Securities’s PTC Therapeutics PTCT Stock Holding History

SBI Securities’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82 Hold
1
– – ﹤0.01% 3553
2026
Q1 		$68 Sell
1
-26
-96% -$1.84K ﹤0.01% 3511
2025
Q4 		$2.05K Buy
27
+26
+2,600% +$1.89K ﹤0.01% 2370
2025
Q3 		$61 Sell
1
-1
-50% -$52 ﹤0.01% 3654
2025
Q2 		$98 Sell
2
-6
-75% -$285 ﹤0.01% 3546
2025
Q1 		$408 Buy
8
+7
+700% +$349 ﹤0.01% 2945
2024
Q4 		$45 Buy
+1
New +$43 ﹤0.01% 3658

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

SBI Securities's PTCT Position: Q2 2026 in Review

SBI Securities held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 1 share worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #3553.

SBI Securities first reported a position in PTCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.05K in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • SBI Securities held 1 share of PTC Therapeutics worth $82 as of Q2 2026.
  • SBI Securities left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3553 holding.
  • SBI Securities first reported a position in PTC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's PTC Therapeutics position peaked at $2.05K in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.